Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IMMUNOe Health and Research Centers is a specialized medical group and clinical research organization (CRO) focused on the diagnosis, treatment, and study of immunological disorders. The organization integrates a clinical practice specializing in allergy, asthma, and immunology with a robust research division that conducts Phase I through IV clinical trials for global pharmaceutical and biotechnology partners. Led by founder Dr. Isaac Melamed, IMMUNOe utilizes an 'Immune-Centric' approach to healthcare, investigating the underlying role of the immune system in various chronic conditions. With multiple facilities across Colorado, the center provides comprehensive patient care while serving as a high-enrollment site for complex clinical protocols in respiratory and inflammatory medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IMMUNOe Health and Research Centers.